<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04637997</url>
  </required_header>
  <id_info>
    <org_study_id>VM_Compression</org_study_id>
    <nct_id>NCT04637997</nct_id>
  </id_info>
  <brief_title>Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations</brief_title>
  <official_title>Influence of Flat-knitted Compression Stockings Class I and II on the Morphology of Venous Malformations - Is There a Therapeutic Effect?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Erlangen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Erlangen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diseases with vascular malformations are rare and often congenital, affecting patients of all&#xD;
      ages. Depending on their extent and localization, they can cause discomfort and, especially&#xD;
      if activity is restricted, lead to loss or reduced quality of life.&#xD;
&#xD;
      The therapy is usually reserved for a few specialized centers and includes interventional&#xD;
      sclerotherapy as well as conservative therapy by compression with appropriate compression&#xD;
      stockings. However, there are currently no study-based recommendations for this approach.&#xD;
&#xD;
      The aim of this study is to prove a therapeutic effect of compression therapy using&#xD;
      flat-knitted compression stockings on venous malformations of the extremities and to derive&#xD;
      from this a therapy recommendation in connection with an improvement in the health status and&#xD;
      quality of life.&#xD;
&#xD;
      For this purpose, patients with a confirmed venous malformation of the upper or lower&#xD;
      extremity independent of previous therapy will be included. We will investigate patients with&#xD;
      epi- and/or subfascial localization of the venous malformation independent of the local&#xD;
      extent (cross-articular or not).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This is a single group study with crossover components. Participants receive randomly and double-blinded either class I compression stockings or class II compression stockings. After four weeks, an exchange of compression classes takes place, so that all participants wear both classes of compression stockings within eight weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-blind study. Neither investigator nor patient knows the compression class (class I versus class II) of the compression stockings used in the different investigation periods in this patient.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI</measure>
    <time_frame>one day</time_frame>
    <description>Determination and comparison of volume difference of the malformation after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by MRI.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre</measure>
    <time_frame>one day</time_frame>
    <description>Determination and comparison of volume difference of the affected extremity after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by perometre.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84</measure>
    <time_frame>up to two months</time_frame>
    <description>SF-12v2 (SOEP-Version 2004) scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental (MCS) and physical (PCS) functioning and overall health-related quality of life.&#xD;
A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. The overall mean for each scale is 50 points and the standard deviation is 10 points in the SOEP sample.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Vascular Malformations</condition>
  <condition>Vascular Malformation Peripheral</condition>
  <condition>Venous Malformation</condition>
  <condition>Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Study group 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Wearing of compression stockings class I between Investigation day 28 to 56. Wearing of compression stockings class II between Investigation day 56 to 84.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Wearing of compression stockings class II between Investigation day 28 to 56. Wearing of compression stockings class I between Investigation day 56 to 84.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>compression stockings class I</intervention_name>
    <description>Daily wearing of compression stockings class I for four weeks on the affected extremity.</description>
    <arm_group_label>Study group 1</arm_group_label>
    <arm_group_label>Study group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>compression stockings class II</intervention_name>
    <description>Daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
    <arm_group_label>Study group 1</arm_group_label>
    <arm_group_label>Study group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a confirmed venous malformation of the upper/lower extremity independent&#xD;
             of previous therapy with epi- and/or subfascial localization of the venous&#xD;
             malformation independent of the local extent (cross-articular or not)&#xD;
&#xD;
          -  Compression stocking can be put on independently or by the parents&#xD;
&#xD;
          -  Written declaration of consent present&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of compliance, patient is not available for control appointments&#xD;
&#xD;
          -  Additional drug therapy (anticoagulation) for extensive venous malformations with&#xD;
             threatening thromboembolic complications&#xD;
&#xD;
          -  Known allergic reaction/intolerance to components of flat-knitted compression&#xD;
             stockings&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Rejection of the study participation by the patient&#xD;
&#xD;
          -  Contraindications for the planned MRI examination (pacemakers, implants not suitable&#xD;
             for MRI, claustrophobia)&#xD;
&#xD;
          -  Occurrence of an emergency situation&#xD;
&#xD;
          -  Severe heart failure as contraindication for compression therapy&#xD;
&#xD;
          -  Peripheral arterial disease as contraindication for compression therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Erlangen, Vascular Surgery</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <results_first_submitted>January 26, 2021</results_first_submitted>
  <results_first_submitted_qc>March 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 16, 2021</results_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Erlangen</investigator_affiliation>
    <investigator_full_name>Dr. med. Antje Mükke</investigator_full_name>
    <investigator_title>Senior physician Dr. med. Antje Mükke</investigator_title>
  </responsible_party>
  <keyword>Compression therapy</keyword>
  <keyword>Compression stockings class I</keyword>
  <keyword>Compression stockings class II</keyword>
  <keyword>Short-Form 12 (SF-12)</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Wearing comfort</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>MRI</keyword>
  <keyword>Perometre</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 18, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT04637997/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were informed about the possibility of participating in the study during a routine presentation of the vascular surgery consultation Hours during 01.10.2017-01.12.2018.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Study Group 1</title>
          <description>Wearing of compression stockings class I between Investigation day 28 to 56. Wearing of compression stockings class II between Investigation day 56 to 84.&#xD;
compression stockings class I: Daily wearing of compression stockings class I for four weeks on the affected extremity.&#xD;
compression stockings class II: Daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
        </group>
        <group group_id="P2">
          <title>Study Group 2</title>
          <description>Wearing of compression stockings class II between Investigation day 28 to 56. Wearing of compression stockings class I between Investigation day 56 to 84.&#xD;
compression stockings class I: Daily wearing of compression stockings class I for four weeks on the affected extremity.&#xD;
compression stockings class II: Daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Study Group 1</title>
          <description>Wearing of compression stockings class I between Investigation day 28 to 56. Wearing of compression stockings class II between Investigation day 56 to 84.&#xD;
compression stockings class I: Daily wearing of compression stockings class I for four weeks on the affected extremity.&#xD;
compression stockings class II: Daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
        </group>
        <group group_id="B2">
          <title>Study Group 2</title>
          <description>Wearing of compression stockings class II between Investigation day 28 to 56. Wearing of compression stockings class I between Investigation day 56 to 84.&#xD;
compression stockings class I: Daily wearing of compression stockings class I for four weeks on the affected extremity.&#xD;
compression stockings class II: Daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.22" spread="18.91"/>
                    <measurement group_id="B2" value="28.11" spread="15.5"/>
                    <measurement group_id="B3" value="27.17" spread="24.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Affected part of body</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>arm</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>lower limb</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>upper limb</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>upper and lower limb</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous therapy</title>
          <description>Number of participants in whom therapy has already been performed related to the venous malformation.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI</title>
        <description>Determination and comparison of volume difference of the malformation after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by MRI.</description>
        <time_frame>one day</time_frame>
        <population>Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Compression Stockings Class I</title>
            <description>Wearing of compression stockings class I on the affected extremity.</description>
          </group>
          <group group_id="O2">
            <title>Compression Stockings Class II</title>
            <description>Wearing of compression stockings class II on the affected extremity.</description>
          </group>
        </group_list>
        <measure>
          <title>Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI</title>
          <description>Determination and comparison of volume difference of the malformation after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by MRI.</description>
          <population>Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.38" spread="18.28"/>
                    <measurement group_id="O2" value="23.7" spread="25.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Volume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre</title>
        <description>Determination and comparison of volume difference of the affected extremity after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by perometre.</description>
        <time_frame>one day</time_frame>
        <population>Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Compression Stocking Class I</title>
            <description>Daily wearing of compression stockings class I for four weeks on the affected extremity.</description>
          </group>
          <group group_id="O2">
            <title>Compression Stockings Class II</title>
            <description>Daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
          </group>
        </group_list>
        <measure>
          <title>Volume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre</title>
          <description>Determination and comparison of volume difference of the affected extremity after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by perometre.</description>
          <population>Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124" spread="351.09"/>
                    <measurement group_id="O2" value="90.22" spread="226.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84</title>
        <description>SF-12v2 (SOEP-Version 2004) scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental (MCS) and physical (PCS) functioning and overall health-related quality of life.&#xD;
A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. The overall mean for each scale is 50 points and the standard deviation is 10 points in the SOEP sample.</description>
        <time_frame>up to two months</time_frame>
        <population>Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Compression Stockings Class I</title>
            <description>Difference between Quality of life after daily wearing of compression stockings class I for four weeks on the affected extremity.</description>
          </group>
          <group group_id="O2">
            <title>Compression Stockings Class II</title>
            <description>Difference between Quality of life after daily wearing of compression stockings class II for four weeks on the affected extremity.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84</title>
          <description>SF-12v2 (SOEP-Version 2004) scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental (MCS) and physical (PCS) functioning and overall health-related quality of life.&#xD;
A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. The overall mean for each scale is 50 points and the standard deviation is 10 points in the SOEP sample.</description>
          <population>Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9505" spread="7.2323"/>
                    <measurement group_id="O2" value="3.3461" spread="7.321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0922" spread="9.6244"/>
                    <measurement group_id="O2" value="0.1778" spread="6.865"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall Health-related Quality of life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5214" spread="4.24"/>
                    <measurement group_id="O2" value="1.762" spread="3.164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected for 18 months during the enrollment, inclusion and investigation period of participants.</time_frame>
      <desc>During the whole Investigation period there were no participants at Risk for All-Cause Mortality because no potentially life-threatening diagnosis, treatment or therapy was performed. Especially there was no use of drugs, contrast agent or other potentially allergy triggering procedures. All procedures related to the study have been performed non-invasively. Nevertheless, all-cause mortality was monitored.</desc>
      <group_list>
        <group group_id="E1">
          <title>Compression Stockings Class I</title>
          <description>Wearing of compression stockings class I on the effected extremity for four weeks between Investigation day 28 to 56 or between Investigation day 56 to 84.</description>
        </group>
        <group group_id="E2">
          <title>Compression Stockings Class II</title>
          <description>Wearing of compression stockings class II on the effected extremity for four weeks between Investigation day 28 to 56 or between Investigation day 56 to 84.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. med. Antje Mükke</name_or_title>
      <organization>University Hospital Erlangen, Vascular Surgery</organization>
      <phone>+4991318532968</phone>
      <email>antje.muekke@uk-erlangen.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

